Category: Regulatory DisclosuresBy adminOctober 31, 2019 Author: admin https://ramedapharma-ir.com Post navigationPreviousPrevious post:EGM Minutes on 4 November 2019NextNext post:Rameda announces its intention to float on the Egyptian ExchangeRelated PostsRameda Announces New Chairman and Additions to its Board of DirectorsJune 3, 2026Rameda Initiates First Acquisition of 2025July 7, 2025Record Dividend Distribution DisclosureJuly 7, 2025BOD-Shareholding-Structure-2024April 15, 2024The invitation to shareholders for the AGMMarch 31, 2024RetractionMarch 24, 2024
